INTELLIA THERAPEUTICS INC (NTLA) Institutional Ownership and Insiders Activity

INTELLIA THERAPEUTICS INC (NTLA) is widely held by institutional investors, with 1 tracked firm reporting positions valued at approximately $186.01M based on SEC Form 13F filings for the quarter ended March 31, 2026.

ARK Invest is the largest disclosed holder, reporting approximately $186.01M in NTLA holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with ARK Invest representing the majority of disclosed value.

Recent insider activity includes 10 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.